Published • loading... • Updated
Study finds MS disease activity stayed low for up to 13 years
Summary by Multiple Sclerosis News Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Study finds MS disease activity stayed low for up to 13 years
Treatment with Ponvory (ponesimod) for up to 13 years was associated with sustained low disease activity in adults with relapsing-remitting multiple sclerosis (RRMS), with relapse rates and brain lesion activity decreasing over time. That’s according to new data from a completed Phase 2b clinical trial (NCT01006265) and its long-term extension study (NCT01093326). The researchers also reported no new […] The post Long-term study finds MS disease…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
